Tag: analysis

The latest market research report highlights significant growth in the seed coating market driven by factors like rising demand for low-cost crop protection and technological advancements. Key players such as BASF SE and Cistronics Innovations are pivotal in this sector. Polymers lead the market due to their enhanced protection and adherence qualities. The cereals & grains segment dominates, primarily driven by the global demand for increased productivity. Asia-Pacific shows the fastest growth, fueled by agricultural expansion and modern farming adoption. This comprehensive report offers in-depth analysis on materials, active ingredients, and regional growth trends, catering to manufacturers and stakeholders aiming for strategic growth in the seed coating industry.

MELBOURNE, Australia and INDIANAPOLIS, July 22, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today provides an update on its commercial and operational performance for the quarter ended 30 June 2025 (Q2 2025). All figures are in USD unless stated otherwise.

[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Naphthalene Sulfonate Market size & share revenue was valued at approximately USD 813.20 Million in 2024 and is expected to reach USD 841.78 Million in 2025 and is expected to reach around USD 1,113.50 Million by 2034, at a CAGR of 3.16% between 2025 and 2034. The key market players listed in the report with their sales, revenues and strategies are Acar Kimya, Akzo Nobel N.V., BASF SE, Enaspol, GCP Applied Technologies Inc., Giovanni Bozzetto S.p.A., Himadri Speciality Chemical Limited, Hunstman International LLC, Kao Corporation, Koppers Inc., MUHU (China) Construction Materials Company Limited, Nease Performance Chemicals, PCC SE, Arkema Group, and Eastman Chemical Company and others.

CAMBRIDGE, Mass., July 21, 2025 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) today announced upcoming scientific presentations at the 2025 Alzheimer’s Association International Conference (AAIC), taking place July 27-31 in Toronto, Canada. Data on LEQEMBI^® (lecanemab) will include 48-month results from the Clarity AD open-label extension, real-world evidence, and new insights into a subcutaneous formulation for maintenance dosing. Presentations on tau will explore tau-targeted therapies and biomarkers, including baseline characteristics of participants from CELIA, a Phase 2 trial evaluating the efficacy, safety, and tolerability of BIIB080, an investigational antisense oligonucleotide (ASO) therapy that targets tau.

SAN FRANCISCO, July 21, 2025 (GLOBE NEWSWIRE) -- Healthcare giant Centene Corporation (NYSE: CNC), a prominent provider of government-sponsored and commercial healthcare services, finds itself embroiled in a class action lawsuit following a dramatic plunge in its stock price. The suit, Lunstrum v. Centene Corporation, No. 25-cv-05659 (S.D.N.Y.), seeks to represent investors who purchased or acquired Centene securities between December 12, 2024, and June 30, 2025, alleging violations of the Securities Exchange Act of 1934.